Hepalink extends and the reason for it is DM betting on using the momentum built up in Zenith trials along with selling some sort of Royalty to a third party to help fund Apabetalone's next kick at the cat.

Glad to see the debenture was extended and no 10:1 share consolidation. I would like to know who has been selling down the shares to this level over the past year or so.   Maybe time to let the share price rip back up to the $1 level. We will see. A real yawner for now.